Evidence map›Paper›PMID 23986439›Full record

ArticleThe Journal of biological chemistry2013

Mutations in SLC2A2 gene reveal hGLUT2 function in pancreatic β cell development.

Aurélien Michau, Ghislaine Guillemain, Alexandra Grosfeld, Sandrine Vuillaumier-Barrot, Teddy Grand, Mathilde Keck, Sébastien L'Hoste, Danielle Chateau, Patricia Serradas, Jacques Teulon and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Aurélien MichauFrom the INSERM UMRS872, Cordeliers Research Center, Université Pierre et Marie Curie, 75006 Paris, France.
Ghislaine Guillemain
Alexandra Grosfeld
Sandrine Vuillaumier-Barrot
Teddy Grand
Mathilde Keck
Sébastien L'Hoste
Danielle Chateau
Patricia Serradas
Jacques Teulon
Pascale De Lonlay
Raphaël Scharfmann
Edith Brot-Laroche
Armelle Leturque
Maude Le Gall
Centre de Recherche des Cordeliers · FRInserm · FRDélégation Paris 5 · FRHôpital Bichat-Claude-Bernard · FRHôpital Necker-Enfants Malades · FRSorbonne Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structure-function relationships of sugar transporter-receptor hGLUT2 coded by SLC2A2 and their impact on insulin secretion and β cell differentiation were investigated through the detailed characterization of a panel of mutations along the protein. We studied naturally occurring SLC2A2 variants or mutants: two single-nucleotide polymorphisms and four proposed inactivating mutations associated to Fanconi-Bickel syndrome. We also engineered mutations based on sequence alignment and conserved amino acids in selected domains. The single-nucleotide polymorphisms P68L and T110I did not impact on sugar transport as assayed in Xenopus oocytes. All the Fanconi-Bickel syndrome-associated mutations invalidated glucose transport by hGLUT2 either through absence of protein at the plasma membrane (G20D and S242R) or through loss of transport capacity despite membrane targeting (P417L and W444R), pointing out crucial amino acids for hGLUT2 transport function. In contrast, engineered mutants were located at the plasma membrane and able to transport sugar, albeit with modified kinetic parameters. Notably, these mutations resulted in gain of function. G20S and L368P mutations increased insulin secretion in the absence of glucose. In addition, these mutants increased insulin-positive cell differentiation when expressed in cultured rat embryonic pancreas. F295Y mutation induced β cell differentiation even in the absence of glucose, suggesting that mutated GLUT2, as a sugar receptor, triggers a signaling pathway independently of glucose transport and metabolism. Our results describe the first gain of function mutations for hGLUT2, revealing the importance of its receptor versus transporter function in pancreatic β cell development and insulin secretion.

Indexed as

Mutation, MissensePolymorphism, Single NucleotideAmino Acid SubstitutionAnimalsBiological Transport, ActiveCell DifferentiationCell Line, TumorGlucoseGlucose Transporter Type 2HumansInsulinInsulin-Secreting CellsInsulin SecretionMiceRatsSignal TransductionGlucoseGlucose Transporter Type 2InsulinSLC2A2 protein, humanCarbohydrate MetabolismFanconi-Bickel SyndromeGlucose TransportGLUT2Insulin SecretionMutantPancreatic IsletsXenopus

Identifiers

PMID23986439
PMCPMC3829421
OpenAlexW2122972109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.